Healthcare Industry News: mobile CT
News Release - March 5, 2007
NeuroLogica Receives Canadian Medical Device License for the CereTom(TM) CT Scanner
Approval Clears the Way for NeuroLogica to Install First Ever Portable CT Scanner in Medical Facilities Throughout CanadaDANVERS, Mass.--(HSMN NewsFeed)--NeuroLogica Corporation, a neuroscience-based medical imaging company, today announced that its CereTom(TM) has received the Canadian Medical License. This approval will allow entry of the CereTom(TM), the first portable and cordless CT scanner, into hospitals, walk-in clinics and private practice medical offices throughout Canada.
Canada's medical device license regulations call for manufacturers to provide substantial scientific evidence of a product's safety, efficacy and quality based on objective evidence, which the CereTom has met. In addition, a medical device must bear a label that contains specific information as described in the regulations.
"This is a major accomplishment for our company, and it will allow us to further our mission, of bringing greater access globally to quality, mobile neuro-imaging," said Eric Bailey, President and Co-founder of NeuroLogica Corporation. "Leading medical centers in the United States and Europe are already using the CereTom in the ER, OR and ICU departments. Additionally, we are opening up distribution networks in Asia and Latin America. Now, hospitals in Canada will have access to more rapid scans for critical patients as NeuroLogica's portable CT scanner will ultimately improve patient care.
The CereTom(TM) is now installed at 30 hospitals and medical centers across the US and Europe including The Massachusetts General Hospital and UCLA Medical Center. NeuroLogica will next apply for the appropriate certification required for global distribution including Japan, China, Hong Kong, Korea, and India.
About NeuroLogica:
Based in Danvers, Mass., NeuroLogica Corporation, a neuro-science based imaging company, develops, manufactures and markets advanced medical imaging equipment. The company's mission is to bring access to high quality neuro-imaging to all people regardless of where they live. Combining superior imaging quality and easy access enables physicians to make more informed treatment decisions that save and improve patient lives, specifically in neuro-related conditions.
Source: NeuroLogica Corp
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
